EP Patent

EP2461811B1 — Macrocyclic serine protease inhibitors useful against viral infections, particularly hcv

Assigned to Idenix Pharmaceuticals LLC · Expires 2016-04-20 · 10y expired

What this patent protects

Patent listed against simeprevir-sodium.

Drugs covered by this patent

Patent Metadata

Patent number
EP2461811B1
Jurisdiction
EP
Classification
—
Expires
2016-04-20
Drug substance claim
No
Drug product claim
No
Assignee
Idenix Pharmaceuticals LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.